Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study
TR-SSCinNICU
1 other identifier
interventional
120
1 country
1
Brief Summary
This study is a multi-center, prospective pre-post clinical study conducted under the leadership of the Turkish Neonatal Society. It aims to investigate the effects of a standardized skin-to-skin care in NICU, initiated early and applied regularly, on recieving exclusive mothers' milk at discharge and clinical outcomes for preterm infants born ≤ 32 weeks of gestation.
- 1.Primary Objective: To evaluate the rate of receiving exclusive mothers' milk at discharge for infants born ≤ 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.
- 2.Secondary Objective: To evaluate the rates of neonatal sepsis, intraventricular hemorrhage, and necrotizing enterocolitis (stage 2 and above) as well as the length of hospital stay for infants born at or below 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
October 31, 2024
CompletedFirst Posted
Study publicly available on registry
November 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedNovember 4, 2024
November 1, 2024
7 months
October 31, 2024
November 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mothers' Milk at Discharge
Number of infants receiving Exclusive Mothers' Milk at Discharge
Through study completion, an average of 3 months, at the time of discharge
Secondary Outcomes (5)
Intraventricular hemorrhage
Through study completion, an average of 3 months, at the time of discharge
Necrotizing enterocolitis (stage 2 and above)
Through study completion, an average of 3 months, at the time of discharge
Early neonatal sepsis
Through study completion, an average of 3 months, at the time of discharge
Late neonatal sepsis
Through study completion, an average of 3 months, at the time of discharge
Length of hospital stay
Through study completion, an average of 3 months, at the time of discharge
Study Arms (2)
Pre education
NO INTERVENTIONThe infants born at less than 32 weeks and discharged from the units in the last two months before training.
Post education
ACTIVE COMPARATORThe infants born at less than 32 weeks and discharged between four to six months after training
Interventions
Early and regular skin to skin contact in NICU GA: \< 28 weeks: After the 72nd hour GA: 28 - 32 weeks: As soon as stabilization is ensured
Eligibility Criteria
You may qualify if:
- Infants born at gestational age ≤ 32 weeks
You may not qualify if:
- Death before NICU discharge
- Abdominal wall defects
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Baskent University Ankara Hospitallead
- Ankara Universitycollaborator
- Gazi Universitycollaborator
- Hacettepe Universitycollaborator
- Marmara Universitycollaborator
- Umraniye Education and Research Hospitalcollaborator
- Trakya Universitycollaborator
- Ege Universitycollaborator
- Ondokuz Mayıs Universitycollaborator
- Cukurova Universitycollaborator
- Sanliurfa Harran Universitycollaborator
- Cumhuriyet Universitycollaborator
- Uludag Universitycollaborator
- Kocaeli Universitycollaborator
- Aydin Adnan Menderes Universitycollaborator
- Konya City Hospitalcollaborator
- Baskent Universitycollaborator
Study Sites (1)
Baskent University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Esin Koc, Prof, MD
Gazi University
- STUDY DIRECTOR
Saadet Arsan, Prof, MD
Ankara University
- STUDY DIRECTOR
Hülya Bilgen, Prof, MD
Marmara University
- STUDY DIRECTOR
İlke Mungan Akın, Prof, MD
Umraniye Teaching and Research Hospital
- STUDY DIRECTOR
Betül Acunaş, Prof, MD
Trakya University
- STUDY DIRECTOR
Mehmet Yalaz, Prof, MD
Ege University
- STUDY DIRECTOR
Sezin Unal, Prof, MD
Baskent University
- STUDY DIRECTOR
Sule Yigit, Prof, MD
Hacettepe University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof, MD
Study Record Dates
First Submitted
October 31, 2024
First Posted
November 4, 2024
Study Start
September 1, 2024
Primary Completion
April 1, 2025
Study Completion
June 1, 2025
Last Updated
November 4, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share